US reform: A tale of two taxes, but device levy is now unstoppable
This article was originally published in Clinica
Executive Summary
Last week’s US Supreme Court decision on the Affordable Care Act points to the single inevitable truth for the medtech lobby: the 2.3% tax on sales of medical devices in the US will be now be levied as of January 2013.